Status:
COMPLETED
Pergolide Treatment for Substance Abusers - 4
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
New York State Psychiatric Institute
Conditions:
Cocaine-Related Disorders
Substance-Related Disorders
Eligibility:
MALE
18-55 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of pergolide for cocaine dependence.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
October 1 1995
Trial Type :
INTERVENTIONAL
End Date :
December 1 2001
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000269
Start Date
October 1 1995
End Date
December 1 2001
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032